Related Experiment Videos
Cellular neurothekeoma with histiocytic differentiation
Noriyuki Misago1, Toshimi Satoh, Yutaka Narisawa
1Division of Dermatology, Department of Internal Medicine, Faculty of Medicine, Saga University, Nabeshima 5-1-1, Saga 849-8501, Japan. misago@post.saga-med.ac.jp
Journal of Cutaneous Pathology
|July 23, 2004
Summary
Cellular neurothekeoma exhibits dual differentiation, expressing markers for both nerve sheath and histiocytic lineages. This finding supports a theory of multiple differentiation potential in these tumors.
Area of Science:
- Oncology
- Pathology
- Immunohistochemistry
Background:
- The classification of cellular neurothekeoma is debated, with some suggesting it as a distinct fibrohistiocytic entity.
- Previous studies indicated cellular neurothekeomas lack histiocytic markers, with PG-M1 being the most reliable.
- This challenges the traditional view of neurothekeoma as a spectrum with myxoid types.
Observation:
- A case of cellular neurothekeoma with typical histopathological features is presented.
- Immunohistochemical analysis revealed neoplastic cells positive for S-100A6, PGP9.5, CD10, CD68 (KP1), PG-M1, and Vimentin.
- The cells were negative for S-100 protein and factor XIIIa.
Findings:
- The expression of both KP-1 and PG-M1 suggests histiocytic differentiation in cellular neurothekeoma.
- Concomitant expression of PGP9.5/S-100A6 and PG-M1/CD68 (KP-1) supports the theory of multiple differentiation.
- The role of CD10 expression in this context remains undetermined.
Implications:
- Cellular neurothekeoma may represent a neoplasm with immature nerve sheath differentiation that incidentally expresses histiocytic markers.
- Alternatively, it could be an undifferentiated neoplasm from the neural crest cell lineage.
- These findings contribute to understanding the complex differentiation pathways in cellular neurothekeomas.